David Windley is ranked #1824 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

David Windley (Jefferies) — Analyst Ratings, Accuracy & Track Record

Q: How accurate are David Windley's stock ratings?

About 59% of David's ratings were profitable over a one-year hold, with an average return of +9.0% per rating, measured by 13Foresight from historical prices.

Analyst Tracker/David Windley

JEF

David Windley

Jefferies

Wall Street Analyst

★★☆☆☆

#1824

on 13Foresight · ranked by our own returns

59%

Success Rate

+9.0%

Average Return

16 of 27 calls profitable · -5.1% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compare To ⓘ

📈 Across the calls we could measure, roughly 59% of David Windley's ratings turned a profit when each position was held for 1 year — averaging +9.0% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

29 Buy 12 Hold 3 Sell

David's Stock Coverage 29 ratings · 2026-06-19

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return
MEDP Medpace Holdings	Jun 15, 2026	BUY	Buy -12.0% avg upside 16 analysts	$490.00 6.52% Upside	·
ICLR Icon	May 28, 2026	BUY	Strong Buy +24.0% avg upside 25 analysts	$135.00 7.46% Downside	+8.0%
CRL Charles River Labs	May 08, 2026	BUY	Strong Buy +12.0% avg upside 34 analysts	$225.00 21.68% Upside	+5.6%
UNH UnitedHealth	Apr 20, 2026	BUY	Strong Buy +2.4% avg upside 35 analysts	$373.00 7.07% Downside	+26.7%
MOH Molina Healthcare	Apr 20, 2026	HOLD	Buy +13.8% avg upside 25 analysts	$139.00 28.76% Downside	+33.4%
CI Cigna	Apr 20, 2026	BUY	Strong Buy +23.8% avg upside 29 analysts	$330.00 18.15% Upside	+2.9%
CNC Centene	Apr 20, 2026	HOLD	Buy +8.7% avg upside 28 analysts	$39.00 36.01% Downside	+58.3%
OSCR Oscar Health	Apr 20, 2026	HOLD	Buy -34.1% avg upside 15 analysts	$16.00 43.72% Downside	+71.9%
ELV Elevance Health	Apr 20, 2026	BUY	Strong Buy +10.8% avg upside 32 analysts	$391.00 0.68% Upside	+22.1%
HUM Humana	Feb 27, 2026	BUY	Buy -11.2% avg upside 34 analysts	$235.00 34.88% Downside	+91.0%
STVN Stevanato Group	Feb 10, 2026	HOLD	Strong Buy +54.2% avg upside 13 analysts	$17.50 0.24% Downside	-85.5%
WST West Pharmaceutical Services	Feb 10, 2026	BUY	Strong Buy +6.5% avg upside 17 analysts	$295.00 9.98% Downside	+35.4%
IQV IQVIA Holdings	Feb 06, 2026	BUY	Strong Buy +34.3% avg upside 38 analysts	$255.00 52.06% Upside	-4.9%
SHC Sotera Health	Nov 20, 2025	BUY	Strong Buy +30.3% avg upside 13 analysts	$19.50 23.29% Upside	-0.1%
FTRE Fortrea Holdings Inc.	Sep 08, 2025	HOLD	Buy -3.5% avg upside 11 analysts	$9.50 37.90% Downside	+30.0%
SLQT SelectQuote	Aug 25, 2025	HOLD	Buy +685.4% avg upside 16 analysts	$3.00 203.57% Upside	-60.3%
STE Steris	Jun 04, 2025	HOLD	Strong Buy +22.1% avg upside 10 analysts	$263.00 29.88% Upside	-11.7%
VEEV Veeva Systems	Jun 02, 2025	BUY	Strong Buy +54.2% avg upside 36 analysts	$335.00 118.50% Upside	-14.5%
NOTVQ Inotiv	Jun 02, 2025	HOLD	Strong Buy +179095.3% avg upside 6 analysts	$2.50 17141.30% Upside	·
CERT Certara	Apr 21, 2025	HOLD	Buy +133.3% avg upside 21 analysts	$14.50 161.74% Upside	-57.1%
CE Celanese	Apr 26, 2021	BUY	Strong Buy +75.9% avg upside 27 analysts	$190.00 271.46% Upside	-10.6%
TDOC Teladoc	Feb 25, 2021	HOLD	Buy +257.8% avg upside 37 analysts	$248.00 2973.14% Upside	-67.8%
MDRX Veradigm	Aug 04, 2020	HOLD	Buy +207.0% avg upside 22 analysts	$8.50 77.16% Upside	+94.5%
EVH Evolent Health	Aug 21, 2017	BUY	Strong Buy +121.1% avg upside 19 analysts	$28.00 523.63% Upside	·
EHTH Ehealth	Dec 02, 2016	HOLD	Hold +869.6% avg upside 19 analysts	$9.50 475.72% Upside	+126.0%
ACH Accendra Health	Dec 02, 2016	HOLD	Hold +439.4% avg upside 17 analysts	$36.00 1014.63% Upside	-42.9%
AON Aon	Dec 02, 2016	BUY	Buy +10.6% avg upside 29 analysts	$129.00 59.34% Downside	+28.8%
MRSH Marsh & McLennan Companies	Nov 28, 2016	HOLD	Buy +17.8% avg upside 29 analysts	$68.00 58.08% Downside	·
ALKS Alkermes	Aug 27, 2009	HOLD	Strong Buy -17.5% avg upside 34 analysts	$11.50 74.50% Downside	+43.6%

🔒 24 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

David Windley — Frequently Asked Questions

How accurate are David Windley's stock ratings?

Based on the calls 13Foresight could measure, about 59% of David's ratings were profitable over a one-year hold, with an average return of +9.0% per rating, or -5.1% versus the S&P 500. We score every analyst the same way, from historical prices.

How is David ranked on 13Foresight?

David Windley is currently ranked #1824 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does David cover?

David most recently has ratings on MEDP, ICLR, CRL, UNH, MOH, CI, CNC, OSCR, ELV, HUM, STVN, WST and 17 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Rating Distribution

Welcome to 13Foresight!